Go Pro
NYSE:WST

West Pharmaceutical Services Q3 2026 Earnings Report

West Pharmaceutical Services logo
$375.93 +4.84 (+1.30%)
Closing price 09/23/2026 03:59 PM Eastern
Extended Trading
$375.81 -0.12 (-0.03%)
As of 04:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services EPS Results

Actual EPS
N/A
Consensus EPS
$2.19
Beat/Miss
N/A
One Year Ago EPS
N/A

West Pharmaceutical Services Revenue Results

Actual Revenue
N/A
Expected Revenue
$825.98 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

West Pharmaceutical Services Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Thursday, October 22, 2026
Conference Call Time
8:00AM ET

Conference Call Resources

West Pharmaceutical Services Earnings Headlines

CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel
Is West Pharmaceutical Services Stock Outperforming the Nasdaq?
See More West Pharmaceutical Services Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like West Pharmaceutical Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your email.

About West Pharmaceutical Services

West Pharmaceutical Services (NYSE:WST) (NYSE: WST) develops and manufactures components and systems used to package, contain and deliver injectable medicines and other healthcare products. Its customers include pharmaceutical, biotechnology and medical device companies, which use West products in drug administration and medical applications.

The company’s offerings include elastomer components such as stoppers, plungers and seals; syringe and cartridge components; vial and container closure systems; and specialized delivery systems for injectable and other complex medicines. West also provides contract-manufactured products and device solutions, including systems designed to support self-administration and other drug-delivery applications.

Founded in 1923, West Pharmaceutical Services is headquartered in Exton, Pennsylvania, and serves customers through manufacturing, development and commercial operations across North America, Europe and Asia. Its business is organized around proprietary products and contract-manufactured products, with a focus on supporting the pharmaceutical and healthcare supply chains.

View West Pharmaceutical Services Profile